North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding – FDA 483, Mar 10, 2022
An FDA inspection of North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding in Richardson, TX, revealed significant deficiencies in both sterile and non-sterile drug production. Observations included the use of non-pharmaceutical grade materials, inadequate aseptic processing controls, microbial contamination, and insufficient process validation, indicating serious risks to product quality and patient safety.
- Inspection date
- March 10, 2022
- Product type
- drugs
ID · 00daecea-cbf1-44b9-b82a-651c9bc82949
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.